These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29785580)

  • 21. The role of mitochondria in statin-induced myopathy.
    Apostolopoulou M; Corsini A; Roden M
    Eur J Clin Invest; 2015 Jul; 45(7):745-54. PubMed ID: 25991405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statin-induced myopathy.
    Gounden R; Blockman M
    Cardiovasc J Afr; 2008; 19(3):156-7. PubMed ID: 18568178
    [No Abstract]   [Full Text] [Related]  

  • 23. Statin-associated myopathy and the quest for biomarkers: can we effectively predict statin-associated muscle symptoms?
    Muntean DM; Thompson PD; Catapano AL; Stasiolek M; Fabis J; Muntner P; Serban MC; Banach M
    Drug Discov Today; 2017 Jan; 22(1):85-96. PubMed ID: 27634340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does simvastatin cause more myotoxicity compared with other statins?
    Backes JM; Howard PA; Ruisinger JF; Moriarty PM
    Ann Pharmacother; 2009 Dec; 43(12):2012-20. PubMed ID: 19920157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk identification and possible countermeasures for muscle adverse effects during statin therapy.
    Magni P; Macchi C; Morlotti B; Sirtori CR; Ruscica M
    Eur J Intern Med; 2015 Mar; 26(2):82-8. PubMed ID: 25640999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of Colchicine-Associated Myopathy in Gout: Influence of Concomitant Use of Statin.
    Kwon OC; Hong S; Ghang B; Kim YG; Lee CK; Yoo B
    Am J Med; 2017 May; 130(5):583-587. PubMed ID: 28065770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SLCO1B1 polymorphism is not associated with risk of statin-induced myalgia/myopathy in a Czech population.
    Hubáček JA; Dlouhá D; Adámková V; Zlatohlavek L; Viklický O; Hrubá P; Češka R; Vrablík M
    Med Sci Monit; 2015 May; 21():1454-9. PubMed ID: 25992810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies.
    Mohassel P; Mammen AL
    Muscle Nerve; 2013 Oct; 48(4):477-83. PubMed ID: 23519993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statin induced myopathy.
    Frank RE
    J Insur Med; 2009; 41(2):132-5. PubMed ID: 19845216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statin-induced myopathy in a patient with previous poliomyelitis.
    Martikainen MH; Gardberg M; Kohonen Ia; Lähdesmäki J
    Am J Phys Med Rehabil; 2013 Nov; 92(11):1031-4. PubMed ID: 23370588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical analysis of 160 cases of statin-induced myopathy].
    Jiang Y; Lou Y; Liu Y; Wang L; Pang H; Zhang J; Zhou Y; Li Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Nov; 42(11):905-9. PubMed ID: 25620251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statin myopathy: a review of recent progress.
    Mammen AL; Amato AA
    Curr Opin Rheumatol; 2010 Nov; 22(6):644-50. PubMed ID: 20827205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statin-Induced Myopathy: Translational Studies from Preclinical to Clinical Evidence.
    Camerino GM; Tarantino N; Canfora I; De Bellis M; Musumeci O; Pierno S
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statin myopathy: a common dilemma not reflected in clinical trials.
    Fernandez G; Spatz ES; Jablecki C; Phillips PS
    Cleve Clin J Med; 2011 Jun; 78(6):393-403. PubMed ID: 21632911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statin myopathy: significant problem with minimal awareness by clinicians and no emphasis by clinical investigators.
    Whayne TF
    Angiology; 2011 Jul; 62(5):415-21. PubMed ID: 21421631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis.
    Harper CR; Jacobson TA
    Curr Opin Lipidol; 2007 Aug; 18(4):401-8. PubMed ID: 17620856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statins and skeletal muscles toxicity: from clinical trials to everyday practice.
    Norata GD; Tibolla G; Catapano AL
    Pharmacol Res; 2014 Oct; 88():107-13. PubMed ID: 24835295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes in 45 patients with statin-associated myopathy.
    Hansen KE; Hildebrand JP; Ferguson EE; Stein JH
    Arch Intern Med; 2005 Dec 12-26; 165(22):2671-6. PubMed ID: 16344427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a detection algorithm for statin-induced myopathy using electronic medical records.
    Sai K; Hanatani T; Azuma Y; Segawa K; Tohkin M; Omatsu H; Makimoto H; Hirai M; Saito Y
    J Clin Pharm Ther; 2013 Jun; 38(3):230-5. PubMed ID: 23530940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Discrete Event Simulation Model to Assess the Economic Value of a Hypothetical Pharmacogenomics Test for Statin-Induced Myopathy in Patients Initiating a Statin in Secondary Cardiovascular Prevention.
    Mitchell D; Guertin JR; Dubois A; Dubé MP; Tardif JC; Iliza AC; Fanton-Aita F; Matteau A; LeLorier J
    Mol Diagn Ther; 2018 Apr; 22(2):241-254. PubMed ID: 29651791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.